What is Prognos Health?
Prognos Health operates as a pivotal provider of clinical and genomic laboratory data, dedicated to enhancing patient outcomes and accelerating commercial analytics for the life sciences industry. The company has established a comprehensive data marketplace, integrating health records for over 325 million patients to offer rapid access to actionable insights. This platform is instrumental for pharmaceutical companies and healthcare professionals seeking to refine treatment strategies and improve patient engagement through precision marketing and advanced data analytics.
How much funding has Prognos Health raised?
Prognos Health has raised a total of $98M across 8 funding rounds:
Multiple Rounds
$15.5M
Series B
$15M
Private Equity
$23M
Series C
$20.5M
Debt
$1M
Private Equity
$23M
Debt (2011): $745K with participation from Undisclosed
Private Equity (2011): $7.7M, investors not publicly disclosed
Series A (2011): $7M supported by Mentortech Ventures, ARC Angel Fund, and Safeguard Scientifics
Series B (2013): $15M featuring Merck Global Health Innovation Fund, MentorTech Ventures, and Safeguard Scientifics
Private Equity (2017): $23M backed by Safeguard Scientifics, Inc. and Merck Global Health Innovation Fund
Series C (2017): $20.5M with participation from Safeguard Scientifics, Hikma Pharmaceuticals, Maywic Select Investments, Hermed Capital, Merck Global Health Innovation Fund, and Cigna
Debt (2020): $1M led by PPP
Private Equity (2023): $23M supported by Cigna Ventures, Safeguard Scientifics, Red & Blue Ventures, and Marshall Wace
Key Investors in Prognos Health
Cigna Ventures
Cigna Ventures is a venture capital fund focused on investments that accelerate Cignas strategic mission of improving the company's customers health, well-being and sense of security. Cigna Ventures is a wholly owned indirect subsidiary of Cigna Corporation .
Safeguard Scientifics
Safeguard Scientifics is a venture capital and private equity company. It provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. The company was established in 1953 and is based in Pennsylvania, United States of America.
Red & Blue Ventures
Red & Blue Ventures is a seed and early-stage venture capital fund that invests in companies from the University of Pennsylvania ecosystem, primarily focusing on the information technology industry. The firm is managed by Penn alumni and targets companies with founders or managers who are affiliated with the university, including students, faculty, or alumni.
What's next for Prognos Health?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and market expansion for Prognos Health. This capital infusion is expected to bolster the company's data infrastructure, expand its marketplace offerings, and deepen its analytical capabilities. Prognos Health is strategically positioned to further solidify its role as a leader in leveraging integrated clinical and genomic data to drive innovation in healthcare, likely focusing on expanding its reach within the pharmaceutical and biotech sectors and enhancing its precision marketing tools.
See full Prognos Health company page
